CINETIQUE Translations
Cinetique Translations began as a one-woman operation in 2002 in Manchester (UK) when Laurence Auffret, a lecturer in translation at the University of Manchester and a qualified biologist, decided to combine her two areas of expertise: languages and life sciences. With an initial focus on the European market, the company’s first lines of business included training, management and language services for a variety of clients, including conducting training programmes for science students participating in Erasmus exchange programmes, acting as public relations manager for a number of international artists, managing cultural programmes and preparing Material Safety Data Sheets and labels for laboratory materials used in the French medical industry.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Atlas Translations Ltd
With Atlas Translations Ltd you get a service that is both personal and professional. This means that your message will be understood in the language and context you need it…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Company Details
Latest Content from PMHub
What do patient stories actually teach us?
Press Releases | July 21, 2026 | Mednet
How do we translate individual experiences into support that helps others and create support that feels personal but remains relevant to many?
Infographic: Are data blind spots putting your launch at risk?
White Papers and Resources | July 16, 2026 | Inizio
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize...
Key takeaways from ASCO® 2026
White Papers and Resources | July 16, 2026 | Inizio
Following ASCO® 2026, Inizio's experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year's congress revealed for pharmaceutical organisations. Together, they...
More Than Pink Walls: What Women-Centric Care Actually Requires
Press Releases | July 15, 2026 | Medscape Education
The phrase "patient-centered care" is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the latest episode of the Hear...
Why faster trials make participant understanding more important than ever
White Papers and Resources | July 15, 2026 | Cuttsy + Cuttsy
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.
Real Chemistry Launches Real Chemistry ANATOMI, an AI Ecosystem Purpose-Built for Healthcare Commercialization
Press Releases | July 14, 2026 | Real Chemistry
The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of business growth and client value
Older trial participants reject bad design, not technology
White Papers and Resources | July 8, 2026 | Cuttsy + Cuttsy
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.
5 key takeaways from the Patient Centricity and Engagement Conference
White Papers and Resources | July 2, 2026 | Cuttsy + Cuttsy
Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.
Women in Healthcare Leadership Have a Lot to Say. Medscape’s Hear From Her Wins an APEX Grand Award.
Press Releases | July 2, 2026 | Medscape Education
Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at...
Moving Beyond the 10%: A New Era in Preterm Birth Prevention
Press Releases | July 1, 2026 | Medscape Education
For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity remains the second leading cause...